Literature DB >> 20697022

Early atherosclerosis exhibits an enhanced procoagulant state.

Julian Ilcheff Borissoff1, Sylvia Heeneman, Evren Kilinç, Peter Kassák, René Van Oerle, Kristien Winckers, José W P Govers-Riemslag, Karly Hamulyák, Tilman M Hackeng, Mat J A P Daemen, Hugo ten Cate, Henri M H Spronk.   

Abstract

BACKGROUND: Thrombin generation in vivo may be important in regulating atherosclerotic progression. In the present study, we examined for the first time the activity and presence of relevant coagulation proteins in relation to the progression of atherosclerosis. METHODS AND
RESULTS: Both early and stable advanced atherosclerotic lesions were collected pairwise from each individual (n=27) during autopsy. Tissue homogenates were prepared from both total plaques and isolated plaque layers, in which the activity of factors (F) II, X, and XII and tissue factor was determined. Microarray analysis was implemented to elucidate local messenger RNA synthesis of coagulation proteins. Part of each specimen was paraffin embedded, and histological sections were immunohistochemically stained for multiple coagulation markers with the use of commercial antibodies. Data are expressed as median (interquartile range [IQR]). Tissue factor, FII, FX, and FXII activities were significantly higher in early atherosclerotic lesions than in stable advanced atherosclerotic lesions. Endogenous thrombin potential and thrombin-antithrombin complex values consolidated a procoagulant profile of early atherosclerotic lesions (endogenous thrombin potential, 1240 nmol/L x min [IQR, 1173 to 1311]; thrombin-antithrombin complex, 1045 ng/mg [IQR, 842.6 to 1376]) versus stable advanced atherosclerotic lesions (endogenous thrombin potential, 782 nmol/L x min [IQR, 0 to 1151]; thrombin-antithrombin complex, 718.4 ng/mg [IQR, 508.6 to 1151]). Tissue factor, FVII, and FX colocalized with macrophages and smooth muscle cells. In addition, multiple procoagulant and anticoagulant proteases were immunohistochemically mapped to various locations throughout the atherosclerotic vessel wall in both early and advanced atherosclerotic stages.
CONCLUSIONS: This study shows an enhanced procoagulant state of early-stage atherosclerotic plaques compared with advanced-stage plaques, which may provide novel insights into the role of coagulation during atherosclerotic plaque progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697022     DOI: 10.1161/CIRCULATIONAHA.109.907121

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  53 in total

Review 1.  New insights into modulation of thrombin formation.

Authors:  Henri M H Spronk; Julian I Borissoff; Hugo ten Cate
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

2.  In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity.

Authors:  Emilia S Olson; Michael A Whitney; Beth Friedman; Todd A Aguilera; Jessica L Crisp; Fred M Baik; Tao Jiang; Stephen M Baird; Sotirios Tsimikas; Roger Y Tsien; Quyen T Nguyen
Journal:  Integr Biol (Camb)       Date:  2012-04-26       Impact factor: 2.192

3.  Splice variants of tissue factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signaling.

Authors:  R Srinivasan; E Ozhegov; Y W van den Berg; B J Aronow; R S Franco; M B Palascak; J T Fallon; W Ruf; H H Versteeg; V Y Bogdanov
Journal:  J Thromb Haemost       Date:  2011-10       Impact factor: 5.824

4.  Antithrombin nanoparticles inhibit stent thrombosis in ex vivo static and flow models.

Authors:  Rohun U Palekar; Chandu Vemuri; Jon N Marsh; Batool Arif; Samuel A Wickline
Journal:  J Vasc Surg       Date:  2015-10-17       Impact factor: 4.268

Review 5.  Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.

Authors:  Jens J Posma; Steven P Grover; Yohei Hisada; A Phillip Owens; Silvio Antoniak; Henri M Spronk; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

6.  Evaluation of various endothelial biomarkers in ankylosing spondylitis.

Authors:  Ali Taylan; Ismail Sari; Didem L Kozaci; Yasar Yildiz; Safak Bilge; Isil Coker; Sergir Maltas; Necati Gunay; Nurullah Akkoc
Journal:  Clin Rheumatol       Date:  2011-05-10       Impact factor: 2.980

Review 7.  Role of plasma kallikrein in diabetes and metabolism.

Authors:  E P Feener; Q Zhou; W Fickweiler
Journal:  Thromb Haemost       Date:  2013-05-16       Impact factor: 5.249

Review 8.  Role of tissue factor in atherothrombosis.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

9.  VKORC1 rs2359612C allele is associated with increased risk of coronary artery disease in the presence of coronary calcification.

Authors:  Yibo Wang; Jinxing Chen; Yu Zhang; Lv Bin; Kai Sun; Weifeng Yu; Jibin Liu; Channa Zhang; Haiqing Shen; Zhihui Hou; Fangfang Yu; Rutai Hui
Journal:  Hum Genet       Date:  2012-08-23       Impact factor: 4.132

Review 10.  "Soluble Tissue Factor" in the 21st Century: Definitions, Biochemistry, and Pathophysiological Role in Thrombus Formation.

Authors:  Vladimir Y Bogdanov; Henri H Versteeg
Journal:  Semin Thromb Hemost       Date:  2015-09-26       Impact factor: 4.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.